Literature DB >> 30648316

Machine learning-based prediction of future breast cancer using algorithmically measured background parenchymal enhancement on high-risk screening MRI.

Ashirbani Saha1, Lars J Grimm1, Sujata V Ghate1, Connie E Kim1, Mary S Soo1, Sora C Yoon1, Maciej A Mazurowski1,2,3.   

Abstract

BACKGROUND: Preliminary work has demonstrated that background parenchymal enhancement (BPE) assessed by radiologists is predictive of future breast cancer in women undergoing high-risk screening MRI. Algorithmically assessed measures of BPE offer a more precise and reproducible means of measuring BPE than human readers and thus might improve the predictive performance of future cancer development.
PURPOSE: To determine if algorithmically extracted imaging features of BPE on screening breast MRI in high-risk women are associated with subsequent development of cancer. STUDY TYPE: Case-control study. POPULATION: In all, 133 women at high risk for developing breast cancer; 46 of these patients developed breast cancer subsequently over a follow-up period of 2 years. FIELD STRENGTH/SEQUENCE: 5 T or 3.0 T T1 -weighted precontrast fat-saturated and nonfat-saturated sequences and postcontrast nonfat-saturated sequences. ASSESSMENT: Automatic features of BPE were extracted with a computer algorithm. Subjective BPE scores from five breast radiologists (blinded to clinical outcomes) were also available. STATISTICAL TESTS: Leave-one-out crossvalidation for a multivariate logistic regression model developed using the automatic features and receiver operating characteristic (ROC) analysis were performed to calculate the area under the curve (AUC). Comparison of automatic features and subjective features was performed using a generalized regression model and the P-value was obtained. Odds ratios for automatic and subjective features were compared.
RESULTS: The multivariate model discriminated patients who developed cancer from the patients who did not, with an AUC of 0.70 (95% confidence interval: 0.60-0.79, P < 0.001). The imaging features remained independently predictive of subsequent development of cancer (P < 0.003) when compared with the subjective BPE assessment of the readers. DATA
CONCLUSION: Automatically extracted BPE measurements may potentially be used to further stratify risk in patients undergoing high-risk screening MRI. LEVEL OF EVIDENCE: 3 Technical Efficacy: Stage 5 J. Magn. Reson. Imaging 2019;50:456-464.
© 2019 International Society for Magnetic Resonance in Medicine.

Entities:  

Keywords:  background parenchymal enhancement; breast MRI; breast mask; high-risk breast cancer patients; high-risk screening; vessel segmentation

Year:  2019        PMID: 30648316      PMCID: PMC6625842          DOI: 10.1002/jmri.26636

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  5 in total

Review 1.  Machine learning in breast MRI.

Authors:  Beatriu Reig; Laura Heacock; Krzysztof J Geras; Linda Moy
Journal:  J Magn Reson Imaging       Date:  2019-07-05       Impact factor: 4.813

Review 2.  Overview of Noninterpretive Artificial Intelligence Models for Safety, Quality, Workflow, and Education Applications in Radiology Practice.

Authors:  Yasasvi Tadavarthi; Valeria Makeeva; William Wagstaff; Henry Zhan; Anna Podlasek; Neil Bhatia; Marta Heilbrun; Elizabeth Krupinski; Nabile Safdar; Imon Banerjee; Judy Gichoya; Hari Trivedi
Journal:  Radiol Artif Intell       Date:  2022-02-02

3.  Breast MRI Background Parenchymal Enhancement Categorization Using Deep Learning: Outperforming the Radiologist.

Authors:  Sarah Eskreis-Winkler; Elizabeth J Sutton; Donna D'Alessio; Katherine Gallagher; Nicole Saphier; Joseph Stember; Danny F Martinez; Elizabeth A Morris; Katja Pinker
Journal:  J Magn Reson Imaging       Date:  2022-02-15       Impact factor: 5.119

Review 4.  Updates in Artificial Intelligence for Breast Imaging.

Authors:  Manisha Bahl
Journal:  Semin Roentgenol       Date:  2021-12-31       Impact factor: 0.709

Review 5.  Applying artificial intelligence technology to assist with breast cancer diagnosis and prognosis prediction.

Authors:  Meredith A Jones; Warid Islam; Rozwat Faiz; Xuxin Chen; Bin Zheng
Journal:  Front Oncol       Date:  2022-08-31       Impact factor: 5.738

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.